ArticleApplied biochemistry and biotechnology2026
Caffeine Sodium Benzoate-Induced Macrophage M1 Polarization Promotes Endothelial Progenitor Cell Dysfunction by Inducing Mitochondrial Dysfunction Via Targeting let-7a-5p/OPA1 Axis.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Our previous study showed that chronic exposure to caffeine sodium benzoate (CSB) can cause endothelial cell dysfunction, but the specific mechanism is unclear. Endothelial progenitor cells (EPCs), as precursors of endothelial cells, can differentiate into vascular endothelial cells and assist in blood vessel repair. This study aimed to investigate the potential impact of CSB on EPC function. CSB containing serum (CSB-CS) were obtained from patients receiving long-term CSB abuse. RAW264.7 macrophages were treated with different concentrations of CSB-CS, and the resulting conditioned medium (CSB-CS_CM) was applied to EPCs to assess its effects. CSB-CS significantly induced M1 polarization of RAW264.7 macrophages. Furthermore, CSB-CS_CM remarkably led to endothelial dysfunction in EPCs, as evidenced by inhibited angiogenesis, increased cell senescence, and elevated levels of the dysfunction markers ET-1 and VCAM-1. Concurrently, CSB-CS_CM also triggered mitochondrial impairment in EPCs, characterized by decreased mitochondrial membrane potential, reduced mitochondrial fusion and increased fission. Notably, these adverse effects on endothelial and mitochondrial function were partially reversed by MASM7, an activator of mitochondrial fusion. Additionally, CSB-CS_CM remarkably reduced the levels of the mitochondrial fusion protein OPA1 in EPC. Mechanistically, let-7a-5p, which targets OPA1 mitochondrial dynamin like GTPase (OPA1), was upregulated by CSB-CS_CM, leading to OPA1 suppression and subsequent mitochondrial and endothelial dysfunction. Collectively, pro-inflammatory macrophages induced by CSB-CS may contribute to EPC dysfunction by impairing mitochondrial function via the let-7a-5p/OPA1 pathway. These findings could provide a foundation for future treatments aimed at addressing endothelial dysfunction caused by CSB.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.